Rheumnow Podcast

Best of PsA on Day 1 Dr. Rachel Tate discusses the best PSA data presented Saturday, November 12, 2002 at ACR22 Convergence.  Abstract 0387: Sleep Quality in Patients with Psoriatic Arthritis and Its Relationship with Activity and Comorbidity Abstract 0377: Differences in Early-onset vs. Late-onset Psoriatic Arthritis: Data from the RESPONDIA and REGISPONSER Studies Can computers tell the differen...

Frailty in Vasculitis Dr. Patricia Harkins sits down with Professor Sebastian Sattui to discuss Abstract 0444, Prevalence of Frailty and Associated Factors in Patients with Vasculitis, being presented on Saturday at ACR22 Convergence. Lupus, Sex and STDs Dr. Kathryn Dao discusses abstract 0939 presented at the ACR22 Convergence meeting in Philadelphia, PA. Abstract 0939: Pilot Study: A Novel Metho...

Dr Jack Cush reviews the news and journal reports from the past week on RheumNow.com and looks forward to highlight sessions in the next few days at ACR Convergence 2022.

QD201 - Seropositive Arthralgia (abstract #1604)   https://youtu.be/uQt_IV3FmZc QD202 -1st Line Anakinra (abstract #L12)    https://youtu.be/QyDVQBnYqn4 QD203 - When to Worry About Malignancy and Myositis (abstract #002)   https://youtu.be/qt-debWfSrY QD204 How to Treat Erosive OA (abstract #L05)    https://youtu.be/5-atRyBsCn4 QD205 - RA Activity During Pregnancy (abstract #0955)    https://youtu...

Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com.  New regulatory decisions about JAK inhibitors and why do women with rheumatic diseases have unfair outcomes?

Dr. Jack Cush discussess the news and journal reports from the past week on RheumNow.com . This week more lupus nephritis, more drug induced lupus and more lupus infections that may kill.

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. Highlighted discussion of implantable stimulators, urine proteomics and gut-immune responses to Prevotella in RA.

Review of Adult-onset Still's Disease by Dr. Jack Cush, Executive Editor of RheumNow.com

Dr. Jack Cush reviews: - Should you do clinical trials? - how to start in clinical trials - Types of studies - Benefits to research

Dr. Jack Cush goes off on "Untitling" (not using proper names/titles) in the clinic, in additon to reports on rheumatologist salaries, new drugs in phase 1-3 development and the range of COVID-19 MSK symptoms -- all from the past week on RheumNow.com.

Drs. Pendleton Wickersham (Arthritis Associates PA, San Antonio, TX), Kevin Winthrop (OHSU, Portland, OR), and Christopher Ritchlin (URMC, Rochester, NY) come together to share their experiences discussing with patients the benefit-risk of a JAK inhibitor.

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.

Thanks to all of you for your kind comments and great reviews of our weekly podcast. Please let us know how we can improve by emailing me (jackcush@rheumnow.com) or recording your suggestion using the "Ask Cush Anything" link on our email and website.

Dr. Jack Cush reviews the news, journal reports, ACR and FDA announcements from the past week on RheumNow.com

Can we predict the bad outcomes? Like when ITP evolves into SLE; or when psoriasis will develop arthritis; or if  Sjogens will develop lymphoma?  Dr. Jack Cush reviews these journal reports and this past weeks news from RheumNow.com

Featuring a discussion with Dr. Susan Shenoi from Seattle Childrens Hospital

Dr. Jack Cush discusses declining survival rates in the USA, FDA approvals of new COVID subvariant boosters and other odd and possibly true new research reports from the past week on RheumNow.com.

Rainbow Rheumatology (8.26.2022) Dr. Jack Cush delivers this weeks rheumatology "weather report" with the best and least of news and journal articles from the past week on RheumNow.com “Climate is what we expect, weather is what we get.” – Mark Twain

Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow and discusses a case of refractory juvenile dermatomyositis with calcinosis.

Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com. This week the run down is based on popularity, measured by rheumatologist engagements on the website and social media.

Dr. Jack Cush reviews the news, FDA approvals, journal articles from the past week on RheumNow; plus viewer questions. This week great hopes for vitamin D, the great unknows of CSA and the great big mess that is the gout.

Drs. Jack Cush and Rachel Tate discuss the launch of the updated StillsNow.com website and the new monthly podcast from StillsNow.com. This podcast ends with a Still's disease quiz for rheumatologists.

QD197 - Still's (or Not) NEJM CPC  https://youtu.be/_xnCaxeqidw QD198 - Still's (or Not) with Daily Fevers   https://youtu.be/J1bezuA-f_s QD199 - Still's (or Not): an FUO Evaluation   https://youtu.be/0qDijCAqEpQ QD200 - Still's (or Not): Fever, Joint pain & Itchy Eyes  https://youtu.be/utvFA1lx1lc

Dr. Jack Cush reviews the news, journal reports and rheumatologist cases from the past week on RheumNow.com. This podcast is brought to you by StillsNow.com - be sure to sign up for our monthly StillsNow email and Monthly StillsNow Podcast.

This week's Stills disease Journal Club features expert discussants Drs. Olga Petryna, Daniel Lovell, Hermine Brunner and Jack Cush. Journal articles reviewed includes:  - CONSIDER Trial. Canakinumab for Treatment of Adult-Onset Still's Disease. Kedor C. Ann Rheum Dis 2020 Aug;79:1090-1097  https://bit.ly/3coPFg0 - TENDER Trial. Tocilizumab in systemic juvenile idiopathic arthritis. De Benedetti F...